Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine, Johns Hopkins Medicine, Children’s Hospital of Philadelphia, and the University of Pittsburgh School of Medicine, along with other members of the COVID-19 International Research Team.
COTA & Sanofi Partner to Leverage Real-World Data and AI to Accelerate Cancer Trials
What You Should Know: – COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi. – The